<乌鸦传媒>Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma Joseph Mikhael, MD, leads a discussion on the DREAMM-7 and DREAMM-8 trials Jul 05, 2024 video
<乌鸦传媒>CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma Joseph Mikhael, MD, leads a discussion on the subgroup analysis of CARTITUDE-4 Jun 27, 2024 video
<乌鸦传媒>Real-World Analysis Identifies Meds Tied to Higher Risk of Liver Injury Case reports may not be as reliable, researchers say Jun 25, 2024
<乌鸦传媒>Using MRD Status to Deescalate Multiple Myeloma Therapy Joseph Mikhael, MD, leads a discussion on the findings of the MRD2STOP study Jun 20, 2024 video
<乌鸦传媒>Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma Joseph Mikhael, MD, leads a roundtable discussion on two positive phase III trials from ASCO Jun 14, 2024 video
<乌鸦传媒>Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma Two trials show positive outcomes Jun 04, 2024
Industry Clinic 鈥� Ad Insights <乌鸦传媒>What Will It Take to Deliver Both Health & Care in Oncology? Jun 04, 2024
<乌鸦传媒>Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma Second belantamab mafodotin-containing triplet to show potency in this setting Jun 02, 2024
<乌鸦传媒>Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise News, features, and commentary about cancer-related issues May 10, 2024
<乌鸦传媒>Ending Oncology's Toxic Relationship With High Chemotherapy Doses Optimizing doses can improve patient outcomes and lower costs May 10, 2024
<乌鸦传媒>Quadruplet Shows 'Excellent Activity' in Myeloma Patients Who Defer HSCT ORR reaches 90% with isatuximab plus KRd in newly diagnosed disease Apr 26, 2024
<乌鸦传媒>FDA Approves Earlier Use of CAR-T Products for Myeloma Carvykti and Abecma move to second- and third-line, respectively Apr 08, 2024
<乌鸦传媒>High Response Rate in R/R Multiple Myeloma With Bispecific Antibody ORR of 71% that deepened over time and favorable safety profile with linvoseltamab Apr 08, 2024
<乌鸦传媒>Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations News, features, and commentary about cancer-related issues Mar 29, 2024
<乌鸦传媒>FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myeloma Cilta-cel, ide-cel win support despite concerns about early mortality risk Mar 16, 2024
<乌鸦传媒>Early Death Risk Muddies Risk-Benefit Assessment of CAR-T Therapies for Myeloma FDA advisory panel to weigh the evidence for cilta-cel, ide-cel in day-long meeting Mar 14, 2024
<乌鸦传媒>A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu News, features, and commentary about cancer-related issues Mar 07, 2024
<乌鸦传媒>Toxic Gas That Sterilizes Medical Devices Prompts Safety Rule Update The EPA is set to take action after public outcry Mar 03, 2024
<乌鸦传媒>Taking Control of the Cancer Journey Kathy Giusti gives patients and healthcare workers advice for navigating cancer treatment Mar 02, 2024 podcast
<乌鸦传媒>Amy Schumer's Diagnosis; FDA Yanks Cancer Drug; Nursing Student Murdered Health news and commentary from around the Web gathered by 乌鸦传媒 staff Feb 26, 2024
<乌鸦传媒>Transforming Shots Into Pills; 'Tip of the Iceberg' for TILs? Food Additives Warning News, features, and commentary about cancer-related issues Feb 23, 2024
<乌鸦传媒>Elotuzumab Misses Mark Again as Frontline Treatment for Multiple Myeloma No PFS benefit from adding the monoclonal antibody to standard therapy Feb 20, 2024
<乌鸦传媒>Pulled Myeloma Drug May Have a Role in Treating the Disease After All Belantamab mafodotin boosts PFS by nearly 2 years when combined with bortezomib, dexamethasone Feb 07, 2024
<乌鸦传媒>When a Revolutionary Cancer Treatment Causes Cancer The potential benefits of CAR T-cell therapies still far outweigh the risks Jan 27, 2024
<乌鸦传媒>How Can Cancer Risk Be Cut in Communities Exposed to Toxins? Group outlines plan to bring the latest testing and treatment to medically underserved minorities Jan 25, 2024
<乌鸦传媒>CAR-T Investigation: FDA Leaders Detail Decision on Cancer Risk Warning Post-treatment cases grow to 22 since products' initial approvals Jan 24, 2024
<乌鸦传媒>FDA Calls for New Boxed Warning on All CAR-T Products Most serious warning would alert patients, providers on potential risk for secondary malignancies Jan 23, 2024
<乌鸦传媒>Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma Subcutaneous administration of the anti-CD38 antibody also made for easier dosing Jan 04, 2024
<乌鸦传媒>Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma? Early-phase experience with ruxolitinib suggests potential role in relapsed/refractory disease Dec 21, 2023 video
<乌鸦传媒>Why Some Myeloma Patients Refuse Stem Cell Transplant Study shows the various factors behind refusal of autologous stem cell transplantation Dec 15, 2023 video
<乌鸦传媒>Four Drugs Top Three for Upfront Treatment of Multiple Myeloma Adding anti-CD38 antibodies boosts response and PFS, but timing, sequencing, cost questioned Dec 13, 2023
<乌鸦传媒>Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials Survival 75% worse compared with outcomes seen in registrational studies Dec 10, 2023
<乌鸦传媒>Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish News, features, and commentary about cancer-related issues Dec 01, 2023
<乌鸦传媒>FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapy Applies to all approved therapies, but benefits still outweigh risks, agency says Nov 28, 2023
<乌鸦传媒>Vitamin D for Neuropathy; Good & Bad News for CAR-T; New Labeling for Surgical Mesh News, features, and commentary about cancer-related issues Nov 10, 2023
<乌鸦传媒>Wearables as Cancer Monitors; No China Price Break; Cancer Mystery in Appalachia News, features, and commentary about cancer-related issues Nov 03, 2023
<乌鸦传媒>Quad Regimen for High-Risk Myeloma Produces High Rates of Durable MRD Negativity Two-thirds of transplant-eligible patients met endpoint with isatuximab/KRd Oct 19, 2023
<乌鸦传媒>Lonely Cancer Deaths; Virtual Reality for Pain; 3D Models May Improve Treatment News, features, and commentary about cancer-related issues Oct 19, 2023
<乌鸦传媒>Chemo Shortage: 'Paycheck to Paycheck'; Cancer Blood Test Shines; Struggling to Live News, features, and commentary about cancer-related issues Oct 06, 2023
<乌鸦传媒>IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myeloma Small retrospective study finds fewer severe infections during periods of replacement therapy Sep 29, 2023
